-
公开(公告)号:HUE061271T2
公开(公告)日:2023-06-28
申请号:HUE18888579
申请日:2018-12-14
Applicant: STEALTH BIOTHERAPEUTICS INC
Inventor: ZHENG GUOZHU , BAMBERGER MARK , SMUKSTE INESE
-
公开(公告)号:AU2013296493B2
公开(公告)日:2018-04-26
申请号:AU2013296493
申请日:2013-07-31
Applicant: STEALTH BIOTHERAPEUTICS INC
Inventor: BAMBERGER MARK , BLAKEY BRIAN , WILSON D TRAVIS
IPC: A61K38/08
Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.
-
公开(公告)号:ES2942631T3
公开(公告)日:2023-06-05
申请号:ES18888579
申请日:2018-12-14
Applicant: STEALTH BIOTHERAPEUTICS INC
Inventor: ZHENG GUOZHU , BAMBERGER MARK , SMUKSTE INESE
Abstract: Se describen péptidos no naturales útiles para el tratamiento y la prevención de lesión por isquemia-reperfusión (p. ej., lesión por isquemia-reperfusión cardiaca) o infarto de miocardio. (Traducción automática con Google Translate, sin valor legal)
-
公开(公告)号:FI3723783T3
公开(公告)日:2023-03-24
申请号:FI18888579
申请日:2018-12-14
Applicant: STEALTH BIOTHERAPEUTICS INC
Inventor: ZHENG GUOZHU , BAMBERGER MARK , SMUKSTE INESE
Abstract: Disclosed are non-natural peptides useful for the treatment and prevention of ischemia-reperfusion injury (e.g., cardiac ischemia-reperfusion injury) or myocardial infarction.
-
公开(公告)号:LT3723783T
公开(公告)日:2023-03-27
申请号:LTUS2018065755
申请日:2018-12-14
Applicant: STEALTH BIOTHERAPEUTICS INC
Inventor: ZHENG GUOZHU , BAMBERGER MARK , SMUKSTE INESE
-
公开(公告)号:AU2013296494B2
公开(公告)日:2018-04-26
申请号:AU2013296494
申请日:2013-07-31
Applicant: STEALTH BIOTHERAPEUTICS INC
Inventor: BAMBERGER MARK , BLAKEY BRIAN , ANDERSEN MARC W , WILSON D TRAVIS
IPC: A61K38/00
Abstract: Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and in some applications, a second active agent chemically linked to the peptide, to subjects in need thereof.
-
-
-
-
-